S&P 500   3,917.80 (+0.94%)
DOW   31,911.08 (+1.19%)
QQQ   321.77 (+0.09%)
AAPL   124.26 (-1.27%)
MSFT   232.83 (-0.19%)
FB   264.53 (-0.50%)
GOOGL   2,070.04 (+0.48%)
AMZN   3,151.69 (-1.34%)
TSLA   728.23 (+4.21%)
NVDA   569.60 (+0.69%)
BABA   249.83 (-1.16%)
CGC   35.59 (+0.79%)
GE   13.16 (+4.53%)
MU   90.77 (+2.88%)
NIO   51.09 (+4.03%)
AMD   85.79 (+1.24%)
T   29.36 (+0.62%)
F   12.00 (+3.27%)
ACB   11.39 (+1.61%)
DIS   199.05 (+0.99%)
BA   226.84 (+6.94%)
NFLX   550.54 (+0.80%)
BAC   36.21 (+1.94%)
S&P 500   3,917.80 (+0.94%)
DOW   31,911.08 (+1.19%)
QQQ   321.77 (+0.09%)
AAPL   124.26 (-1.27%)
MSFT   232.83 (-0.19%)
FB   264.53 (-0.50%)
GOOGL   2,070.04 (+0.48%)
AMZN   3,151.69 (-1.34%)
TSLA   728.23 (+4.21%)
NVDA   569.60 (+0.69%)
BABA   249.83 (-1.16%)
CGC   35.59 (+0.79%)
GE   13.16 (+4.53%)
MU   90.77 (+2.88%)
NIO   51.09 (+4.03%)
AMD   85.79 (+1.24%)
T   29.36 (+0.62%)
F   12.00 (+3.27%)
ACB   11.39 (+1.61%)
DIS   199.05 (+0.99%)
BA   226.84 (+6.94%)
NFLX   550.54 (+0.80%)
BAC   36.21 (+1.94%)
S&P 500   3,917.80 (+0.94%)
DOW   31,911.08 (+1.19%)
QQQ   321.77 (+0.09%)
AAPL   124.26 (-1.27%)
MSFT   232.83 (-0.19%)
FB   264.53 (-0.50%)
GOOGL   2,070.04 (+0.48%)
AMZN   3,151.69 (-1.34%)
TSLA   728.23 (+4.21%)
NVDA   569.60 (+0.69%)
BABA   249.83 (-1.16%)
CGC   35.59 (+0.79%)
GE   13.16 (+4.53%)
MU   90.77 (+2.88%)
NIO   51.09 (+4.03%)
AMD   85.79 (+1.24%)
T   29.36 (+0.62%)
F   12.00 (+3.27%)
ACB   11.39 (+1.61%)
DIS   199.05 (+0.99%)
BA   226.84 (+6.94%)
NFLX   550.54 (+0.80%)
BAC   36.21 (+1.94%)
S&P 500   3,917.80 (+0.94%)
DOW   31,911.08 (+1.19%)
QQQ   321.77 (+0.09%)
AAPL   124.26 (-1.27%)
MSFT   232.83 (-0.19%)
FB   264.53 (-0.50%)
GOOGL   2,070.04 (+0.48%)
AMZN   3,151.69 (-1.34%)
TSLA   728.23 (+4.21%)
NVDA   569.60 (+0.69%)
BABA   249.83 (-1.16%)
CGC   35.59 (+0.79%)
GE   13.16 (+4.53%)
MU   90.77 (+2.88%)
NIO   51.09 (+4.03%)
AMD   85.79 (+1.24%)
T   29.36 (+0.62%)
F   12.00 (+3.27%)
ACB   11.39 (+1.61%)
DIS   199.05 (+0.99%)
BA   226.84 (+6.94%)
NFLX   550.54 (+0.80%)
BAC   36.21 (+1.94%)
Log in
OTCMKTS:NTII

Neurobiological Technologies Stock Forecast, Price & News

$0.0078
0.00 (0.00 %)
(As of 02/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.00
MA: $0.01
$0.02
52-Week Range
$0.00
Now: $0.01
$0.02
Volume42 shs
Average Volume35,100 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.8
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NTII
CUSIPN/A
CIKN/A
Phone510-595-6000
Employees4
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1814th out of 1,958 stocks

Biological Products, Except Diagnostic Industry

175th out of 177 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0078
0.00 (0.00 %)
(As of 02/23/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NTII News and Ratings via Email

Sign-up to receive the latest news and ratings for NTII and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Neurobiological Technologies (OTCMKTS:NTII) Frequently Asked Questions

What stocks does MarketBeat like better than Neurobiological Technologies?

Wall Street analysts have given Neurobiological Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Neurobiological Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Neurobiological Technologies' key executives?

Neurobiological Technologies' management team includes the following people:
  • Mr. John B. Stuppin, Founder & Director (Age 87, Pay $28.12k)
  • Mr. Stephen C. Ferruolo, Sec.

Who are some of Neurobiological Technologies' key competitors?

What is Neurobiological Technologies' stock symbol?

Neurobiological Technologies trades on the OTCMKTS under the ticker symbol "NTII."

How do I buy shares of Neurobiological Technologies?

Shares of NTII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neurobiological Technologies' stock price today?

One share of NTII stock can currently be purchased for approximately $0.01.

How many employees does Neurobiological Technologies have?

Neurobiological Technologies employs 4 workers across the globe.

What is Neurobiological Technologies' official website?

The official website for Neurobiological Technologies is www.ntii.com.

Where are Neurobiological Technologies' headquarters?

Neurobiological Technologies is headquartered at 2000 POWELL STREET SUITE 800, EMERYVILLE CA, 94608.

How can I contact Neurobiological Technologies?

Neurobiological Technologies' mailing address is 2000 POWELL STREET SUITE 800, EMERYVILLE CA, 94608. The company can be reached via phone at 510-595-6000.


This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.